{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:40:17Z","timestamp":1765546817618,"version":"3.41.2"},"reference-count":39,"publisher":"Open Access Pub","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJGH"],"abstract":"<jats:p>The study was aimed to evaluate the antioxidant and anti-inflammatory activity of the Biofield Energy Treated Proprietary Test Formulation and Biofield Energy Treatment per se to the animals on Cecal Slurry, LPS and E. coli-induced systemic inflammatory response syndrome (SIRS) model in Sprague Dawley rats. In this experiment, different antioxidants biomarkers such as myeloperoxidase (MPO), superoxide dismutase (SOD), lipid peroxidase (LPO) and cytokines like interleukin-6 (IL-6), tumor necrosis factor-\u03b1 (TNF-\u03b1), macrophage inflammatory protein-2 (MIP-2) were analysed using ELISA assay in brain homogenate. A test formulation was formulated including minerals (magnesium, zinc, calcium, selenium, and iron), vitamin C, B6, E, B12, D3, \u03b2-carotene, cannabidiol isolate,and Panax ginseng extract. The component of the test formulation were divided into two parts; one section was defined as the untreated, while the other portion of each constituent and three group of animals received Biofield Energy Healing\/Blessing Treatment remotely for about 3 minutes by Mr. Mahendra Kumar Trivedi, a renowned spiritual Energy Healer. The level of MPO was significantly (p\u22640.001) reduced by 19.43%, 34.91%, 25.43%, 25.29% and 30.33% in the G5 (Cecal Slurry, LPS and E. coli + Biofield Energy Treated test formulation); G6 (Cecal Slurry, LPS and E. coli + Biofield Energy Treatment per se to animals from day -15); G7 (Cecal Slurry, LPS and E. coli + Biofield Energy Treated test formulation from day -15); G8 (Cecal Slurry, LPS and E. coli + Biofield Energy Treatment per se + Biofield Energy Treated\/Blessed test formulation from day -15), and G9 (Cecal Slurry, LPS and E. coli + Biofield Energy Treatment per se animals + untreated test formulation) groups, respectively as compared to the untreated test formulation (G4) group. Moreover, the level of SOD was significantly increased by 45.02% (p\u22640.001), 16.59%, and 35.99% (p\u22640.001) in the G6, G7, and G9 groups, respectively as compared to G4 group. The level of TNF-\u03b1 was significantly decreased by 12.66%, 46.92% (p\u22640.001), 26.57% (p\u22640.001), 23.22% (p\u22640.001), and 54.28% (p\u22640.001) in G5, G6, G7, G8, and G9 groups, correspondingly with reference to G4 group. Moreover, the level of IL-6 was significantly (p\u22640.001) decreased by 37.51%, 20.28%, 21.55%, and 33.4% in the G6, G7, G8, and G9 groups, respectively as compared to the G4 group. Additionally, the level of MIP-2 was significantly (p\u22640.001) reduced by 47.97%, 17.08%, 20.16% and 26.84% in the G6, G7, G8, and G9 groups, respectively as compared to the G4 group. Together, the data imply the antioxidant and anti-inflammatory potential of the Biofield Energy Treated test formulation and Biofield Energy Treatment per se along with preventive measure on the animal with respect to various inflammatory conditions that might be beneficial various types of systemic inflammatory disorders specially sepsis, trauma, septic shock or any types of injuries. Therefore, the results described a significant reduction of inflammation-related disease progression rate and its complications in the preventive maintenance groups (viz. G6, G7, G8, and G9).<\/jats:p>","DOI":"10.14302\/issn.2693-1176.ijgh-21-3886","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T10:31:12Z","timestamp":1627727472000},"page":"13-25","source":"Crossref","is-referenced-by-count":1,"title":["Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Brain Tissues in Cecal Slurry, LPS and E. Coli-Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats"],"prefix":"10.14302","volume":"1","author":[{"given":"Mahendra Kumar","family":"Trivedi","sequence":"first","affiliation":[{"name":"Trivedi Global, Inc., Henderson, USA."}]},{"given":"Alice","family":"Branton","sequence":"additional","affiliation":[{"name":"Trivedi Global, Inc., Henderson, USA."}]},{"given":"Dahryn","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Trivedi Global, Inc., Henderson, USA"}]},{"given":"Snehasis","family":"Jana","sequence":"additional","affiliation":[{"name":"Trivedi Science Research Laboratory Pvt. Ltd., Thane (W), Maharashtra, India."}]}],"member":"5410","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.Shah S, Kimberly W T. (2016) Today&apos;s approach to treating brain swelling in the neuro intensive care unit. , Semin Neurol 36(6), 502-507.","DOI":"10.1055\/s-0036-1592109"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.Jarrott B, Williams S J. (2016) Chronic brain inflammation: The neurochemical basis for drugs to reduce inflammation. , Neurochem Res 41, 523-533.","DOI":"10.1007\/s11064-015-1661-7"},{"key":"ref2","unstructured":"3.Wang W Y, Tan M S, Yu J T, Tan L. (2015) Role of pro-inflammatory cytokines released from microglia in Alzheimer&apos;s disease. , Ann Transl Med 3(10), 136."},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4.Bender Vishal C Mehra Vinod S Ramgolam Jeffrey R. (2005) Cytokines and cardiovascular disease. 78, 805-817.","DOI":"10.1189\/jlb.0405182"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.Rittner H L, Labuz D, Richter J F, Brack A, Sch\u00e4fer M et al. (2007) CXCR1\/2 ligands induce p38 MAPK-dependent translocation and release of opioid peptides from primary granulesin vitroandin vivo. , Brain Behav Immun 21(8), 1021-32.","DOI":"10.1016\/j.bbi.2007.05.002"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.K De Filippo, Henderson R B, Laschinger M, Hogg N. (2008) Neutrophil chemokines KC and macrophage-inflammatory protein-2 are newly synthesized by tissue macrophages using distinct TLR signalling pathways. , J Immunol 180(6), 4308-15.","DOI":"10.4049\/jimmunol.180.6.4308"},{"key":"ref6","unstructured":"7.Younus H. (2018) Therapeutic potentials of superoxide dismutase. , Int J Health Sci (Qassim) 12(3), 88-93."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8.Rayman M P. (2000) The importance of selenium to human health. , Lancet 356, 233-241.","DOI":"10.1016\/S0140-6736(00)02490-9"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9.Beard J L, Connor J R. (2003) Iron status and neural functioning. , Ann Rev Nutr 23, 41-58.","DOI":"10.1146\/annurev.nutr.23.020102.075739"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.Peres F F, Lima A C, JEC Hallak, Crippa J A, Silva R H.Ab\u00edlio VC (2018) Cannabidiol as a promising strategy to treat and prevent movement disorders?. , Front Pharmacol 9, 482.","DOI":"10.3389\/fphar.2018.00482"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.Nagarkatti P, Pandey R, Rieder S A, Hegde V L, Nagarkatti M. (2009) Cannabinoids as novel anti-inflammatory drugs. , Future Med Chem 1(7), 1333-1349.","DOI":"10.4155\/fmc.09.93"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.Kang S, Min H. (2012) Ginseng, the &apos;Immunity Boost&apos;: The effects ofPanax ginsengon immune system. , J Ginseng Res 36(4), 354-368.","DOI":"10.5142\/jgr.2012.36.4.354"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.Maizes V, Rakel D, Niemiec C. (2009) Integrative medicine and patient-centered care. , Explore (NY) 5(5), 277-289.","DOI":"10.1016\/j.explore.2009.06.008"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.Bischof M, Del Giudice E. (2013) Communication and the emergence of collective behavior in living organisms: A quantum approach. Mol Biol Int. 987549.","DOI":"10.1155\/2013\/987549"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15.Cassidy C M. (2004) What does it mean to practice an energy medicine?. , J Altern Complement Med 10(1), 79-81.","DOI":"10.1089\/107555304322848986"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.Barnes P M, Bloom B, Nahin R L. (2008) Complementary and alternative medicine use among adults and children: United States. , Natl Health Stat Report 12, 1-23.","DOI":"10.1037\/e623942009-001"},{"key":"ref16","unstructured":"17.Fan K wai. (2005) National Center for Complementary and Alternative Medicine Website. , J Med Libr Assoc 93, 410-412."},{"key":"ref17","unstructured":"18.Wisneski L, Anderson L. (2009) The Scientific Basis of Integrative Medicine. , Boca Raton, FL: 205."},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19.Trivedi M K, Branton A, Trivedi D, Jana S. (2021) Isotopic abundance ratio analysis of consciousness energy healing treated folic acid. , Food Nutr Current Res 4(2), 290-295.","DOI":"10.14302\/issn.2576-6694.jbbs-21-3773"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20.Trivedi M K, Branton A, Trivedi D, Nayak G, Mondal S C et al. (2015) Morphological characterization, quality, yield and DNA fingerprinting of biofield energy treated alphonso mango (Mangifera indicaL.). , Journal of Food and Nutrition Sciences 3, 245-250.","DOI":"10.11648\/j.jfns.20150306.18"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21.Trivedi M K, Jana.S (2019)In vitroassessment of the biofield treated test item on cardiac function using rat cardiomyocytes cell line (H9c2)viamultiparametric analysis. , Journal of Hypertension and Cardiology 2(4), 1-12.","DOI":"10.14302\/issn.2329-9487.jhc-19-2582"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"22.Trivedi M K, Branton A, Trivedi D, Jana S. (2021) Effect of consciousness energy healing treatment on the metal profile and properties of tellurium. , Eng Technol Open Acc 3(5), 555623.","DOI":"10.19080\/ETOAJ.2021.03.555623"},{"key":"ref22","unstructured":"23.Mahendra K T, Alice B, Dahryn T, Snehasis J. (2021) Consciousness energy healing treatment impacted the isotopic abundance ratio of 6-Mercaptopurine (6-MP). Nov Appro Drug Des Dev. 5(5), 555673."},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24.Trivedi M K, Jana S. (2021) Anti-aging activity of biofield energy treated novel proprietary test formulation by assessment of vital biomarkers in cerebrospinal fluid (CSF) in Sprague Dawley rats. , On J Neur & Br Disord 5(2).","DOI":"10.23880\/aabsc-16000163"},{"key":"ref24","unstructured":"25.Trivedi M K, Jana S. (2021) Evaluation of biofield energy healing treatment based proprietary test formulation on gut health potential in colon cancer cell line (HT-29). , J Pharmacol Clin Res 8(4), 555743."},{"key":"ref25","unstructured":"26.Trivedi M K, Branton A, Trivedi D, Jana S. (2020) The consciousness energy healing treatment and its impact on the isotopic abundance ratio analysis of flutamide. , Drug Des Int Prop Int J 3(5), -."},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27.Chen S, Chen H, Du Q, Shen J. (2020) Targeting myeloperoxidase (MPO) mediated oxidative stress and inflammation for reducing brain ischemia injury: Potential application of natural compounds. , Front Physiol 11, 433.","DOI":"10.3389\/fphys.2020.00433"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28.Hoy A, Leininger-Muller B, Poirier O, Siest G, Gautier M et al. (2003) Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome. , Atherosclerosis 167(2), 223-30.","DOI":"10.1016\/s0021-9150(02)00041-2"},{"key":"ref28","unstructured":"29.Younus H.Therapeutic potentials of superoxide dismutase. , Int J Health Sci (Qassim) 12(3), 88-93."},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30.Yasui K, Baba A. (2006) Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation. , Inflamm Res 55(9), 359-63.","DOI":"10.1007\/s00011-006-5195-y"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31.Zaghloul N, Patel H, Codipilly C, Marambaud P, Dewey S et al. (2014) Overexpression of extracellular superoxide dismutase protects against brain injury induced by chronic hypoxia. , PLoS ONE 9(9), 108168.","DOI":"10.1371\/journal.pone.0108168"},{"key":"ref31","unstructured":"32.Feuerstein G Z, Liu T, Barone F C. (1994) Cytokines, inflammation, and brain injury: Role of tumor necrosis factor-alpha. , Cerebrovasc Brain Metab Rev Winter 6(4), 341-60."},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33.Wang J, Yang Z, Liu C, Zhao Y, Chen Y. (2013) Activated microglia provide a neuroprotective role by balancing glial cell-line derived neurotrophic factor and tumor necrosis factor-\u03b1 secretion after subacute cerebral ischemia. , International Journal of Molecular Medicine 31(1), 172-178.","DOI":"10.3892\/ijmm.2012.1179"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"34.Muhammad M. (2019) Tumor necrosis factor alpha: A major cytokine of brain neuro-inflammation.","DOI":"10.5772\/intechopen.85476"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35.Erta M, Quintana A, Hidalgo J. (2012) Interleukin-6, a major cytokine in the central nervous system. , Int J Biol Sci 8(9), 1254-1266.","DOI":"10.7150\/ijbs.4679"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36.Dalla Libera AL, Regner A, J de Paoli, Centenaro L, Martins T T et al. (2011) IL-6 polymorphism associated with fatal outcome in patients with severe traumatic brain injury. , Brain Injury 25, 365-9.","DOI":"10.3109\/02699052.2011.556107"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37.Qin C C, Liu Y N, Hu Y, Yang Y, Chen Z. (2017) Macrophage inflammatory protein-2 as mediator of inflammation in acute liver injury. , World J Gastroenterol 23(17), 3043-3052.","DOI":"10.3748\/wjg.v23.i17.3043"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"38.Tomita M, Holman B J, Santoro C P. (2005) Astrocyte production of the chemokine macrophage inflammatory protein-2 is inhibited by the spice principle curcumin at the level of gene transcription. , J Neuroinflammation 2, 8.","DOI":"10.1186\/1742-2094-2-8"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39.Wang J Y, Shum A Y, Chao C C, Kuo J S, Wang J Y. (2000) Production of macrophage inflammatory protein-2 following hypoxia\/reoxygenation in glial cells. , Glia 32(2), 155-64.","DOI":"10.1002\/1098-1136(200011)32:2<155::aid-glia50>3.0.co;2-4"}],"container-title":["International Journal of Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/openaccesspub.org\/ijgh\/article\/1667","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T10:31:57Z","timestamp":1627727517000},"score":1,"resource":{"primary":{"URL":"https:\/\/openaccesspub.org\/ijgh\/article\/1667"}},"subtitle":[],"editor":[{"given":"ANUBHA","family":"BAJAJ","sequence":"additional","affiliation":[{"name":"Consultant Histopathology, A.B. Diagnostics, New Delhi, India."}]}],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,11,30]]}},"URL":"https:\/\/doi.org\/10.14302\/issn.2693-1176.ijgh-21-3886","relation":{},"ISSN":["2693-1176"],"issn-type":[{"type":"electronic","value":"2693-1176"}],"subject":[],"published":{"date-parts":[[2021,7,23]]},"article-number":"1667"}}